Testing ticagrelor alone after a heart attack and stent
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether a single blood thinner (ticagrelor) is safe and helps reduce bleeding in the heart muscle in people who have had a specific type of heart attack (STEMI) and a stent. It may be an option if you want to avoid taking aspirin with ticagrelor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a specific type of heart attack called ST-elevation myocardial infarction (STEMI).
- You had a successful procedure to open the blocked artery with a modern drug-coated stent.
- You have not had a heart attack or stent procedure in the past 12 months.
- You do not take any blood thinners (other than aspirin).
- You are not allergic to aspirin, ticagrelor, or prasugrel.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
This trial tests whether taking ticagrelor (a blood thinner) alone, without aspirin, is safe and effective for people who have had a heart attack and are being treated with medication only (no stents or bypass surgery). It could mean fewer pills and possibly reduce bleeding risks.
This study tests if a single blood thinner (ticagrelor) works well enough after getting a heart stent, instead of the usual two blood thinners. It may simplify your daily medication routine.
This study compares ticagrelor taken at a lower dose versus regular aspirin to help prevent future heart attacks in people who recently had a stent placed after acute coronary syndrome. You may qualify if you’re considered “high risk” for new blockages or clots and can take dual anti-platelet therapy for 12 months.
This trial tests whether a lower dose of aspirin is safe and effective for patients who have had a heart attack (STEMI) and received a stent. If you've been taking aspirin and ticagrelor after your procedure, you may be able to join.
Hear when a new ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.